Drug Channels Institute (DCI) is a leading source of industry research about pharmaceutical economics and the drug distribution system. >

Industry Reports

The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >

The 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >

From The Drug Channels Blog

The Direct-to-Patient Opportunity: Evolving Pharma’s DTP Strategy for Lasting Patient Engagement

Today's guest post comes from Sahil Naik, Chief Growth Officer at PHIL Inc. Sahil examines how direct-to-patient programs may be able to support affordability and patient engagement throughout the more >

Your Hub May Be Working. Your Provider Still May Be Drowning.

Today's guest post comes from Randy Quist, Vice President, Field Reimbursement at Inizio Engage. Randy examines how patient support hubs and field reimbursement managers can work together to support more >